EOM 1352: Fri 7 June 2024, 11:36

Current Edition

Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Regional News

Neuland to Open Commercial Peptide Facility as Part of Planned Phased Expansion

Neuland Laboratories  will open its new commercial peptide facility in the summer of 2026 at its 17-acre Bonthapally manufacturing campus, with further capacity expa...
Continue Reading →
Regional News

LabConnect Expands Global Central Laboratory Infrastructure with Wuxi, China Facility

LabConnect has officially opened a new central laboratory facility in Wuxi, China, developed in collaboration with Teddy Laboratory (Frontage Laboratories). The site...
Continue Reading →
Regional News

EAU 2026: Late-Breaking Erda-iDRS Data Delivers New Momentum in Bladder Cancer

Johnson & Johnson presented new late-breaking First-in-Human (FIH) Phase 1 data for Erda-iDRS (TAR-210), an investigational intravesical drug-releasing system, d...
Continue Reading →
Regional News

CANCER RESEARCH UK AND NOVALGEN DOSE THE FIRST PATIENT IN THE PHASE 1 TRIAL OF T-CELL ENGAGER NVG-222

Cancer Research UK's Centre for Drug Development (CDD) and NovalGen today announce that the first patient has been dosed in a Phase 1 clinical trial evaluating NVG‑2...
Continue Reading →
Regional News

START Appoints Dr. Frank Smith President of its XenoSTART Preclinical Research Business Unit

Dr. Smith will strengthen XenoSTART’s position as a premier drug development partner, translating PDX-driven insights into faster, more confident oncology developmen...
Continue Reading →
Regional News

Wisdom Bioscience Establishes Scientific Advisory Board to Advance Oral Cancer Diagnostics and Screening

Wisdom Bioscience, Inc., a biotechnology company pioneering non-invasive oral cancer diagnostics, today announced the formation of its Scientific Advisory Board (SAB...
Continue Reading →
Regional News

Expert Perspectives on Metabolic Drug Development

Interest in the development of new therapies to treat endocrine and metabolic diseases has skyrocketed, driven in part by increased commercial success and medical ef...
Continue Reading →
Regional News

Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukaemia (CML) Therapy asciminib

Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced its Simcyp® Simulator enabled physiologically-based pharmacokinetic...
Continue Reading →
Regional News

Upperton Submits MHRA Licence Application for Annex 1 Sterile Manufacturing Facility Following APS Validation

Upperton has submitted its application to the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the approval of its new 7,000 sq. ft sterile manufact...
Continue Reading →
Regional News

Pumas 2.8 Sets a New Standard for Clinical Pharmacology and Pharmacometrics Technology with Embedded AI and Next Generation Estimation

PumasAI, a science-first organisation that turns data into life-saving decisions faster, today announced the release of Pumas version 2.8 to bring significant advanc...
Continue Reading →
Catalyst: 12th January 2026
Quotient